This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ozanne, G Articles by d'Halewyn, M A Search for Related Content PubMed PubMed Citation Articles by Ozanne, G Articles by d'Halewyn, M A

Performance and reliability of the Enzygnost measles enzyme-linked immuno-sorbent assay for detection of measles virus-specific immunoglobulin M antibody during a large measles epidemic.

Laboratoire de Santé Publique du Québec, Immunodiagnostic, Ste-Anne-de-Bellevue, Canada.

ABSTRACT

Evaluation of the Enzygnost Measles Enzyme-Linked Immuno-Sorbent Assay kit (Behring) performance to detect specific immunoglobulin M (IgM) was carried out with 3,297 single serum samples and 898 paired serum samples collected during a measles epidemic (10,184 reported cases) in Quebec, Canada. Anti-measles IgM and IgG were detected by using the Enzygnost kit with the appropriate conjugates. Complement-fixing (CF) antibody (Ab) titers were assessed by the laboratory branch complement fixation micromethod. The Centers for Disease Control's clinical measles case definition was used. A modification of the manufacturer's optical density interpretation algorithm was introduced to allow for equivocal results, in addition to positive and negative ones. These three categories differed as to their association with a significant increase in CF Ab titer and the time between the onset of symptoms and phlebotomy. The IgM positivity rate for complement fixation-confirmed measles cases was 96.6% for vaccinated subjects and 100% for nonvaccinated subjects. The daily percentage of IgM seropositivity that was detected for subjects who became IgM positive within 30 days increased gradually from 40 to 90% for sera taken 1 to 7 days after the onset of symptoms, and it plateaued at 100% for sera taken 16 to 30 days after the onset of symptoms. IgM seropositivity was strongly associated with IgG seroconversion, CF Ab titer increase, and clinical measles (P less than 0.0001). Reproducibility was 100% for nonreactive sera and 99.1% for reactive sera. In conclusion, the Enzygnost Measles Enzyme-Linked Immuno-Sorbent Assay kit performed adequately to confirm measles virus infection during this epidemic. A second serum sample should be tested when an early-acute-phase serum sample is IgM negative.

This article has been cited by other articles:

• Tipples, G. A., Hamkar, R., Mohktari-Azad, T., Gray, M., Parkyn, G., Head, C., Ratnam, S. (2003). Assessment of Immunoglobulin M Enzyme Immunoassays for Diagnosis of Measles. J. Clin. Microbiol. 41: 4790-4792 [Abstract] [Full Text]  
• Ratnam, S., Tipples, G., Head, C., Fauvel, M., Fearon, M., Ward, B. J. (2000). Performance of Indirect Immunoglobulin M (IgM) Serology Tests and IgM Capture Assays for Laboratory Diagnosis of Measles. J. Clin. Microbiol. 38: 99-104 [Abstract] [Full Text]  
• Bouche, F. B., Brons, N. H. C., Houard, S., Schneider, F., Muller, C. P. (1998). Evaluation of Hemagglutinin Protein-Specific Immunoglobulin M for Diagnosis of Measles by an Enzyme-Linked Immunosorbent Assay Based on Recombinant Protein Produced in a High-Efficiency Mammalian Expression System. J. Clin. Microbiol. 36: 3509-3513 [Abstract] [Full Text]  
• Bouche, F., Ammerlaan, W., Berthet, F., Houard, S., Schneider, F., Muller, C. P. (1998). Immunosorbent Assay Based on Recombinant Hemagglutinin Protein Produced in a High-Efficiency Mammalian Expression System for Surveillance of Measles Immunity. J. Clin. Microbiol. 36: 721-726 [Abstract] [Full Text]